These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 22530904)

  • 21. Synthesis and Biological Evaluations of NO-Donating Oxa- and Aza-Pentacycloundecane Derivatives as Potential Neuroprotective Candidates.
    Sharma R; Joubert J; Malan SF
    Molecules; 2018 Jan; 23(2):. PubMed ID: 29385098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and synthesis of methyl 2-methyl-7,7-dihalo-5-phenyl-2-azabicyclo[4.1.0]hept-3-ene-4-carboxylates with calcium channel antagonist activity.
    Mojarrad JS; Miri R; Knaus EE
    Bioorg Med Chem; 2004 Jun; 12(12):3215-20. PubMed ID: 15158789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Block of voltage-dependent calcium channels by aliphatic monoamines.
    Beedle AM; Zamponi GW
    Biophys J; 2000 Jul; 79(1):260-70. PubMed ID: 10866952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorescent polycyclic ligands for nitric oxide synthase (NOS) inhibition.
    Joubert J; van Dyk S; Malan SF
    Bioorg Med Chem; 2008 Oct; 16(19):8952-8. PubMed ID: 18805011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, rotamer orientation, and calcium channel modulation activities of alkyl and 2-phenethyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(3- or 6-substituted-2-pyridyl)-5-pyridinecarboxylates.
    Iqbal N; Akula MR; Vo D; Matowe WC; McEwen CA; Wolowyk MW; Knaus EE
    J Med Chem; 1998 May; 41(11):1827-37. PubMed ID: 9599233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of novel bridged tetrahydronaphthalene derivatives as potent T/L-type calcium channel blockers.
    Renneberg D; Hubler F; Rey M; Hess P; Delahaye S; Gatfield J; Iglarz M; Hilpert K
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3941-6. PubMed ID: 26231163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, and preliminary pharmacological evaluation of 4-aminopiperidine derivatives as N-type calcium channel blockers active on pain and neuropathic pain.
    Teodori E; Baldi E; Dei S; Gualtieri F; Romanelli MN; Scapecchi S; Bellucci C; Ghelardini C; Matucci R
    J Med Chem; 2004 Nov; 47(24):6070-81. PubMed ID: 15537361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NMDA receptor expression and activity in osteoarthritic human articular chondrocytes.
    Ramage L; Martel MA; Hardingham GE; Salter DM
    Osteoarthritis Cartilage; 2008 Dec; 16(12):1576-84. PubMed ID: 18554934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-activity relationships of diphenylpiperazine N-type calcium channel inhibitors.
    Pajouhesh H; Feng ZP; Ding Y; Zhang L; Pajouhesh H; Morrison JL; Belardetti F; Tringham E; Simonson E; Vanderah TW; Porreca F; Zamponi GW; Mitscher LA; Snutch TP
    Bioorg Med Chem Lett; 2010 Feb; 20(4):1378-83. PubMed ID: 20117000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful reduction of off-target hERG toxicity by structural modification of a T-type calcium channel blocker.
    Choi YJ; Seo JH; Shin KJ
    Bioorg Med Chem Lett; 2014 Feb; 24(3):880-3. PubMed ID: 24412109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological evaluation of 4-piperidinecarboxylate and 4-piperidinecyanide derivatives for T-type calcium channel blockers.
    Woo HM; Lee YS; Roh EJ; Seo SH; Song CM; Chung HJ; Pae AN; Shin KJ
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5910-5. PubMed ID: 21843937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
    Ramesh M; Matowe WC; Akula MR; Vo D; Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Knaus EE
    J Med Chem; 1998 Feb; 41(4):509-14. PubMed ID: 9484501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Voltage-dependent calcium channels in the rat retina: involvement in NMDA-stimulated influx of calcium.
    Melena J; Osborne NN
    Exp Eye Res; 2001 Apr; 72(4):393-401. PubMed ID: 11273667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nefopam inhibits calcium influx, cGMP formation, and NMDA receptor-dependent neurotoxicity following activation of voltage sensitive calcium channels.
    Novelli A; Díaz-Trelles R; Groppetti A; Fernández-Sánchez MT
    Amino Acids; 2005 Mar; 28(2):183-91. PubMed ID: 15714253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. L-Type calcium channel blockers: from diltiazem to 1,2,4-oxadiazol-5-ones via thiazinooxadiazol-3-one derivatives.
    Budriesi R; Cosimelli B; Ioan P; Ugenti MP; Carosati E; Frosini M; Fusi F; Spisani R; Saponara S; Cruciani G; Novellino E; Spinelli D; Chiarini A
    J Med Chem; 2009 Apr; 52(8):2352-62. PubMed ID: 19323482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and pharmacological evaluation of pyrimidobenzothiazole-3-carboxylate derivatives as selective L-type calcium channel blockers.
    Chikhale R; Thorat S; Pant A; Jadhav A; Thatipamula KC; Bansode R; Bhargavi G; Karodia N; Rajasekharan MV; Paradkar A; Khedekar P
    Bioorg Med Chem; 2015 Oct; 23(20):6689-713. PubMed ID: 26385444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
    Randle JC; Guet T; Bobichon C; Moreau C; Curutchet P; Lambolez B; de Carvalho LP; Cordi A; Lepagnol JM
    Mol Pharmacol; 1992 Feb; 41(2):337-45. PubMed ID: 1371583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracellular calcium elevation during plateau potentials mediated by extrasynaptic NMDA receptor activation in rat hippocampal CA1 pyramidal neurons is primarily due to calcium entry through voltage-gated calcium channels.
    Oda Y; Kodama S; Tsuchiya S; Inoue M; Miyakawa H
    Eur J Neurosci; 2014 May; 39(10):1613-23. PubMed ID: 24674276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery, structure-activity relationship study, and oral analgesic efficacy of cyproheptadine derivatives possessing N-type calcium channel inhibitory activity.
    Yamamoto T; Niwa S; Iwayama S; Koganei H; Fujita S; Takeda T; Kito M; Ono Y; Saitou Y; Takahara A; Iwata S; Yamamoto H; Shoji M
    Bioorg Med Chem; 2006 Aug; 14(15):5333-9. PubMed ID: 16616501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New oxapolycyclic cage amines with NMDA receptor antagonist and trypanocidal activities.
    Duque MD; Camps P; Torres E; Valverde E; Sureda FX; López-Querol M; Camins A; Prathalingam SR; Kelly JM; Vázquez S
    Bioorg Med Chem; 2010 Jan; 18(1):46-57. PubMed ID: 19954985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.